Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg).
Olmedo L, Calvet X, Gené E, Bordin DS, Voynovan I, Castro-Fernandez M, Pabón-Carrasco M, Keco-Huerga A, Perez-Aisa Á, Lucendo AJ, Rodrigo L, Sarsenbaeva AS, Khlinov IB, Fadieienko G, Zaytsev O, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Jonaitis L, Núñez Ó, Pellicano R, Hernández L, Gridnyev O, Kupcinskas J, Gasbarrini A, Boltin D, Niv Y, Babayeva G, Marcos-Pinto R, Tepes B, Venerito M, Papp V, Lerang F, Leja M, Phull PS, Marlicz W, Doulberis M, Smith SM, Milivojevic V, Kunovsky L, Mestrovic A, Matysiak-Budnik T, Simsek H, Cano-Català A, Puig I, Moreira L, Parra P, Nyssen OP, Megraud F, O'Morain C, Gisbert JP; Hp-EuReg investigators*. Olmedo L, et al. Gut. 2024 Dec 10;74(1):15-25. doi: 10.1136/gutjnl-2024-332804. Gut. 2024. PMID: 39461739 Free PMC article.
Effectiveness and Safety of First-Line Non-Bismuth Quadruple Concomitant Therapy Versus Single-Capsule Bismuth Quadruple Therapy.
Nyssen OP, Montes N, Pérez-Aísa Á, Martínez-Domínguez SJ, Tejedor-Tejada J, Lucendo AJ, Huguet JM, Garre A, Bujanda L, Pabón-Carrasco M, Castro-Fernández M, Perona M, Ortiz-Polo I, Núñez Ó, Marcos MS, Gómez Rodríguez BJ, Loro AM, Bermejo F, Barrio J, Iyo E, Alonso EB, Flores V, Keco-Huerga A, Mata-Romero P, Gomez-Camarero J, Fernández-Bermejo M, Cajal MD, Martin-Holgado D, Velayos B, Planella M, Alcaide N, Blanco ABP, Fernández-Salazar L, Pajares Villarroya R, Alonso MS, Mejide PP, Jiménez-Moreno M, Perelló A, Pascual-Mato M, Albéniz E, Hernández G, Gonzalez MF, Sanchez SM, de Castro JDF, Cano-Català A, Parra P, Moreira L, Mégraud F, O'Morain C, Gisbert JP; Hp‐EuReg investigators. Nyssen OP, et al. Aliment Pharmacol Ther. 2025 Oct;62(8):809-820. doi: 10.1111/apt.70261. Epub 2025 Jul 4. Aliment Pharmacol Ther. 2025. PMID: 40616238